Veracyte (VCYT) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Veracyte (VCYT) Halted on LUDP
November 7, 2017 9:31 AM ESTVeracyte (NASDAQ: VCYT) Halted on LUDP
... MoreVeracyte, Inc (VCYT) PT Lowered to $9 at Leerink Partners
November 7, 2017 8:10 AM ESTLeerink Partners lowered its price target on Veracyte, Inc (NASDAQ: VCYT) to $9.00 (from $12.00) while maintaining an Outperform rating following lower than expected Q3 revenue and guidance.
Analyst Puneet Souda is keeping the Outperform rating on the view that the company offers differentiated negative... More
Janney Montgomery Scott Downgrades Veracyte, Inc (VCYT) to Neutral
November 7, 2017 7:09 AM ESTJanney Montgomery Scott downgraded Veracyte, Inc (NASDAQ: VCYT) from Buy to Neutral.
For an analyst ratings summary and ratings history on Veracyte, Inc click here. For more ratings news on Veracyte, Inc click here.
Shares of Veracyte, Inc closed at $8.26 yesterday.
... MorePiper Jaffray Downgrades Veracyte, Inc (VCYT) to Neutral
November 7, 2017 4:49 AM ESTPiper Jaffray downgraded Veracyte, Inc (NASDAQ: VCYT) from Overweight to Neutral with a price target of $8.00 (from $10.00).
Analyst William Quirk believes the company is a show-me story following the disappointing Q3 earnings report. The analyst believes managements guidance to be cash flow... More

